Skip To Main Content
 

Incident and Prevalent counts by quarter

Incident counts of reported ESRD, 2014 Q1 - 2016 Q2
2014^ 2015^ 2016^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2
0 - 19 301 260 240 288 264 297 271 266 282 265
20 - 44 3,684 3,537 3,366 3,465 3,745 3,619 3,417 3,456 3,677 3,420
45 - 64 12,192 11,916 11,138 11,705 12,763 12,039 11,397 11,781 12,583 11,571
65 - 74 8,002 7,828 7,404 7,864 8,423 8,104 7,658 8,061 8,893 8,338
75 + 7,405 7,108 6,463 6,934 7,552 7,313 6,836 7,076 7,679 6,919
Male 18,443 17,723 16,503 17,701 19,142 18,287 17,024 17,838 19,285 17,555
Female 13,141 12,926 12,108 12,555 13,605 13,085 12,555 12,802 13,829 12,958
Diabetes 14,379 13,457 12,559 13,853 14,904 14,078 13,303 14,304 15,414 13,774
Hypertension 8,998 8,779 8,267 8,607 9,485 9,029 8,313 8,176 8,994 8,132
Glomerulonephritis 2,389 2,374 2,191 2,208 2,358 2,401 2,217 2,294 2,454 2,146
Cystic kidney 675 687 621 599 661 686 690 812 888 869
Other urologic 385 353 365 370 364 343 333 447 436 425
Other cause 2,854 3,090 2,862 2,803 2,948 2,888 2,870 3,135 3,207 3,022
Unknown cause 830 816 751 754 796 733 629 127 143 106
Missing cause 1,074 1,093 995 1,062 1,231 1,214 1,224 1,345 1,578 2,039
All 31,584 30,649 28,611 30,256 32,747 31,372 29,579 30,640 33,114 30,513

^ Data as of September 30, 2016
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Point prevalent counts of reported ESRD, 2014 Q1 - 2016 Q2
2014^ 2015^ 2016^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2
0 - 19 7,669 7,639 7,582 7,606 7,628 7,644 7,600 7,601 7,636 7,635
20 - 44 104,625 105,080 105,092 105,223 105,628 106,046 105,936 105,861 105,997 106,087
45 - 64 295,236 298,066 299,820 301,666 304,198 306,726 308,393 310,382 312,684 314,532
65 - 74 151,085 153,429 155,978 158,420 160,535 162,794 165,220 167,582 170,049 172,694
75 + 107,266 108,388 109,322 110,176 110,541 111,782 113,234 114,470 115,456 116,532
Male 382,448 386,584 389,834 393,396 396,950 401,128 404,317 407,822 411,798 415,138
Female 283,351 285,936 287,879 289,614 291,500 293,786 295,989 297,998 299,948 302,267
Unknown 82 82 81 81 80 78 77 76 76 75
Diabetes 252,312 254,953 256,885 259,312 261,698 264,420 266,621 269,203 271,875 273,980
Hypertension 168,156 170,289 172,046 173,570 175,415 177,385 178,840 179,966 181,424 182,694
Glomerulonephritis 109,404 110,037 110,533 111,018 111,429 112,073 112,573 113,036 113,516 113,843
Cystic kidney 31,675 31,932 32,140 32,300 32,494 32,739 32,977 33,371 33,782 34,192
Other urologic 11,200 11,214 11,292 11,336 11,335 11,378 11,416 11,521 11,567 11,675
Other cause 57,326 58,024 58,478 58,758 59,030 59,540 60,003 60,776 61,180 61,659
Unknown cause 25,352 25,395 25,378 25,353 25,303 25,293 25,242 24,679 24,177 23,755
Missing cause 10,456 10,758 11,042 11,444 11,826 12,164 12,711 13,344 14,301 15,682
All 665,881 672,602 677,794 683,091 688,530 694,992 700,383 705,896 711,822 717,480

^ Data as of September 30, 2016
* Suppressed due to inadequate sample size.
. Zero values in this cell.
Reported Medical Evidence Form data for the incident ESRD population, 2014 Q1 - 2016 Q2
2014^ 2015^ 2016^
Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2 Qtr3 Qtr4 Qtr1 Qtr2
White 20,165 19,884 18,436 19,618 21,028 20,291 19,226 19,809 21,378 19,231
Black/African American 8,368 7,882 7,470 7,774 8,526 7,987 7,371 7,724 8,148 7,432
Native American/Alaska Native 306 276 276 294 304 287 268 263 300 305
Asian 1,283 1,167 1,103 1,179 1,291 1,221 1,131 1,184 1,361 1,219
Pacific Islander 366 340 321 317 353 361 369 358 410 379
Other/Unknown * * * * * * . * * *
No ME Form 1,095 1,097 1,003 1,072 1,242 1,222 1,214 1,295 1,516 1,944
Hispanic 4,444 4,090 3,940 4,227 4,541 4,377 3,989 4,242 4,704 4,020
Non-Hispanic 26,045 25,459 23,666 24,955 26,961 25,770 24,376 25,099 26,894 24,547
Unknown . * * * * * . * . *
No ME Form 1,095 1,097 1,003 1,072 1,242 1,222 1,214 1,295 1,516 1,944
Hemodialysis (%)1 90.4 89.2 89.9 91.4 90.8 89.7 89.1 90.2 90.4 89.7
CAPD (%)1 4.1 5.0 4.8 4.4 4.7 5.4 5.8 5.2 4.7 4.9
CCPD (%)1 5.4 5.8 5.2 4.2 4.5 4.9 5.1 4.6 4.9 5.4
Other (%)1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
UnKnown (%)1 . 0.0 . . . . . . . .
Cathether Only (%)2 61.6 61.4 61.3 61.8 61.9 61.1 61.4 62.8 62.5 62.1
Catheter w/ maturing AVF (%)2 17.2 16.9 16.2 17.0 17.2 16.6 15.8 15.8 16.1 16.6
Catheter w/ maturing AVG (%)2 1.9 1.8 1.7 1.8 1.7 1.8 1.8 1.7 1.6 1.6
AVF (%)2 16.6 16.6 17.5 16.4 16.2 17.3 17.8 16.6 16.7 16.4
AVG (%)2 2.6 3.0 3.1 2.9 2.8 3.0 3.1 3.0 2.9 3.1
Other(%)2 0.2 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.1
Unknown(%)2 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.2
Pre-ESRD EPO(% Yes)3 14.3 14.5 14.4 14.1 13.5 13.6 13.6 13.2 13.3 12.9
Pre-ESRD Nephrology(% Yes)3 70.7 71.7 72.6 72.1 72.8 74.0 74.5 73.9 74.5 75.6
Mean Serum Albumin(g/dL)4 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2 3.2
Mean Serum Creatinine(mg/dL)4 6.6 6.6 6.6 6.5 6.6 6.5 6.5 6.5 6.5 6.4
Mean Hemoglobin(g/dL)4 9.5 9.5 9.6 9.4 9.4 9.4 9.4 9.4 9.3 9.4
All 31,584 30,649 28,611 30,256 32,747 31,372 29,579 30,640 33,114 30,513
All with ME Form 30,489 29,552 27,608 29,184 31,505 30,150 28,365 29,345 31,598 28,569
Dialysis Pts with ME Form 29,852 28,916 26,957 28,516 30,950 29,532 27,729 28,769 31,112 28,040
Hemodialysis Pts w/ ME Form 26,995 25,789 24,246 26,064 28,092 26,503 24,703 25,936 28,134 25,144

^ Data as of September 30, 2016.
* Suppressed due to inadequate sample size.
. Zero values in this cell.
1 Primary type of dialysis percentages shown are based on denominator 'Dialysis Patients with ME Form' counts.
2 Vascular access type percentages shown are based on denominator 'Hemodialysis Patients with ME Form' counts.
Pre-ESRD EPO represents CMS Medical Evidence ESRD new form question 18a. 'Did patient receive exogenous erythropoetin or equivalent?''
Pre-ESRD Nephrology represents CMS Medical Evidence ESRD new form question 18b. 'Was patient under care of nephrologist?''
3 Pre-ESRD EPO and Pre-ESRD Nephrology Percentages shown are based on denominator 'All with ME Form' counts.
4 Mean laboratory test values shown are based on denominator 'All with ME Form' counts.